Aprea Therapeutics Cash from Financing (TTM) Trends

Aprea Therapeutics Inc (APRE)

5.37 +0.25 (+4.88%) USD | NASDAQ | Apr 23, 16:00

5.37 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2019. Upgrade now.

Date	Value
December 31, 2023	5.14M
September 30, 2023	5.238M
June 30, 2023	5.823M
March 31, 2023	5.823M
December 31, 2022	0.683M
September 30, 2022	2.244M
June 30, 2022	1.747M
March 31, 2022	1.747M
December 31, 2021	1.747M

Date	Value
September 30, 2021	0.087M
June 30, 2021	0.00
March 31, 2021	0.1214M
December 31, 2020	0.1509M
September 30, 2020	91.35M
June 30, 2020	87.73M
March 31, 2020	87.17M
December 31, 2019	92.58M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

Minimum

Jun 2021

92.58M

Maximum

Dec 2019

22.90M

Average

2.244M

Median

Sep 2022

Cash from Financing (TTM) Benchmarks